News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
NeOnc Technologies Holdings, Inc. held an investor conference call to discuss results from the Phase 2a portion of its NEO100-01 study. The company's stock is currently trading at $3.21, down 66% over the past six months, despite analysts maintaining price targets between $13 and …
Stonegate Capital Partners has updated its coverage on NeOnc Technologies Holdings, Inc. (NTHI) for 2Q26, highlighting significant clinical advancements for its lead programs NEO100 and NEO212. NEO100 achieved a positive Phase 2a readout with strong progression-free survival and overall survival rates, moving towards a …
Neonode Inc. reported its Q2 2026 financial results, revealing a wider-than-expected loss of $0.13 per share against an estimated $0.11 loss. The company's revenue for the quarter was $477,000, a 20.4% decrease from Q2 2025, and it posted a net loss of $2.1 million …
Neonode (NASDAQ: NEON) reported second-quarter EPS of $-0.130, missing analyst estimates by $0.02. Revenue for the quarter was $500K, falling short of the consensus estimate of $876K. The company's stock has seen significant declines over the past 3 and 12 months, and its financial …
Neonode Inc. reported a 20.4% revenue decrease in Q2 2026 to $0.5 million, primarily due to lower non-recurring engineering revenue, despite a 9.2% increase in license revenue. The company recorded a $2.1 million loss and a reduction in cash reserves to $21.7 million. CEO …
Neonc Technologies Holdings Inc. stock surged 11.3% in pre-open trading after its Phase 2a NEO100-01 study met its primary endpoint with a statistically significant six-month progression-free survival rate. The surge was amplified by the stock trading near its 52-week low, a tight float, high …
This article provides an overview of NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) stock, including its current price, daily range, and trading volume. It also lists key fundamental data such as previous close, market cap, and P/E ratio, while noting several financial metrics are currently …
NeOnc Technologies Holdings announced positive Phase 2a results for its intranasal NEO100 therapy in recurrent IDH1-mutant high-grade glioma, showing a six-month progression-free survival rate of 48.9%, significantly exceeding the 20% benchmark. The study also reported a median overall survival of 26.09 months and a …
This article reports on a Form 8K filing by NEONODE INC. for August 12. The brief announcement provides no specific details from the filing but notes the company's stock symbol is NEON.
Neonode Inc. reported a significant decline in its Q2 2026 revenue, which fell by 20.4% to $0.5 million, primarily due to an 81.5% drop in non-recurring engineering revenue. The company's losses widened to $2.1 million, or $0.13 per share, compared to $1.98 million a …
Neonode (NEON) reported a 20.4% decline in Q2 2026 revenue from continuing operations, reaching $0.5 million, with a net loss of $2.1 million. While license revenue increased, non-recurring engineering revenue significantly dropped. The company also noted a decrease in cash and accounts receivable, and …
Neonode (NASDAQ: NEON) reported a 20.4% year-over-year revenue decline in Q2 2026, totaling $0.5 million, primarily due to a sharp drop in non-recurring engineering revenue despite growth in software licensing. The company's loss per share widened to $0.13, and operating cash use increased, indicating …
Neonode Inc. reported a significant loss of $4.0 million for the first half of 2026 and only $0.48 million in revenue for Q2 2026, marking a 20.4% decline year-over-year. The company maintains a high gross margin due to its licensing model but continues to …
Neonode Inc. reported its 2026 quarterly results with revenue of $477K and a diluted loss per share of ($0.13), a decrease compared to the prior year. The company saw a strategic shift towards MultiSensing licensing, particularly in automotive and IT/industrial, with license fee revenue …
NeOnc Technologies reported positive topline results from its Phase 2a study of intranasal NEO100, showing a median overall survival of 26.09 months and a six-month progression-free survival (PFS-6) of 48.9%, significantly exceeding the 20% protocol benchmark. The treatment was well tolerated with low-grade adverse …
NeOnc Technologies reported positive topline Phase 2a results for its intranasal NEO100 therapy in patients with recurrent IDH1-mutant high-grade glioma, meeting its primary endpoint with a six-month progression-free survival of 48.9%. The therapy showed encouraging median overall survival of 26.09 months and was well-tolerated …
Neonode Inc (NASDAQ:NEON) is slated to release its Q2 2026 earnings on August 12, 2026, with revenue expected at $0.88 million and earnings at $-0.11 per share. Despite past misses on revenue and earnings, GuruFocus estimates a 47% upside from its current price of …
NeOnc Technologies Holdings (NASDAQ: NTHI) is anticipated to release topline Phase 2a results for its intranasal NEO100 therapy for recurrent IDH1-mutant high-grade glioma on August 12. Market observers are noting a "triple confluence setup" for a potential high-impact catalyst, considering the stock's recent 52-week …
A user named AigooHensemboi thanks another user, Trytosaveabit, for a heads-up on NeOnc Technologies (NTHI.US), which resulted in a 10% return on investment (ROI). The post is a brief message from the Moomoo community feed, highlighting a positive trading outcome.
NeOnc Technologies Holdings Inc. (NASDAQ:NTHI) is set to announce topline results from its phase 2a study of intranasal NEO100 for recurrent IDH1-mutant high-grade glioma on Tuesday, with an investor call scheduled for August 12, 2026. The company reported a net loss of $14.2 million …
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported its Q2 2026 financial results, with revenue of $0 and a net loss of $(14.24M), resulting in a diluted loss per share of $(0.58). Despite the financial loss, the company highlighted significant clinical progress, pipeline expansion for NEO212, …
NeOnc Technologies Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026, highlighting significant clinical and regulatory advancements for its NEO100 and NEO212 programs. The company confirmed that topline results from its Phase 2a NEO100 study in recurrent IDH1-mutant high-grade …
NeOnc Technologies Holdings, Inc. (NTHI) reported a net loss of $23.1 million for the first six months of 2026, alongside an accumulated deficit of $135.8 million, raising substantial doubt about its ability to continue as a going concern. Despite raising approximately $20 million through …
This article provides an overview of NeOnc Technologies Holdings, Inc. (NTHI) stock, including its current price, market capitalization, key financial metrics, and analyst forecasts. It highlights the company's status as a clinical-stage biopharmaceutical company developing novel technology for central nervous system diseases. The article …
This article provides an earnings forecast for Neonode Inc (NEON), noting that no earnings forecast score is currently available. It highlights an average price target of $6.00 based on zero analysts, indicating a 156.41% upside. The report also details expected revenue for the next …
This article announces that NEONODE INC. filed a Form 8K on August 7th. The brief news item from Investing.com is part of a larger financial news platform, indicating standard corporate disclosure. No further details about the content of the 8K filing are provided within …
This article provides current stock information for NeOnc Technologies Holdings Inc (NTHI), including its stock price, market cap, and a note that more news will be available soon. It highlights that the company's stock is trading at $3.500 with no change and has a …
Neonode Inc. has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement, as its common stock closed below $1.00 for 30 consecutive business days. The company has a 180-day grace period, until February 2, 2027, to regain compliance by having …
Neonode (NEON) received a notice from Nasdaq on August 6, 2026, indicating noncompliance with the $1.00 minimum bid price rule. The company has 180 days, until February 2, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten …
Search by ticker symbol or company name and select a result to open its chart.